1717 K Street NW, Suite 900

Washington, DC 20006-5349

(877) 363-6376

HELPLINE

NEWS

MESO TV: Sacituzumab targeting TROP-2 for mesothelioma

Our Patient Services Director, Julie White, RN, BSN, OCN, sits down with Michael Offin, MD to discuss a clinical trial . Dr. Offin is a Thoracic Medical Oncologist at Memorial Sloan Kettering Cancer Center. They discuss a current clinical trial for mesothelioma.

Our Sponsors

MesoTV is a program by the Mesothelioma Applied Research Foundation. This program is made possible by our generous sponsors: Belluck Law, Dean Omar Branham Shirley, LLP; Maune Raichle Hartley French & Mudd, LLC (MRHFM); Merck; Bristol Myers Squibb; The Gori Law Firm

Search our previous episodes for topics/speakers of interest to you at www.curemeso.org/mesotv.

Also...

In Other News

Pleural Surgery

Surgery is vital option for treatment for many patients with pleural mesothelioma. This session discusses how pleural surgery works and why it is an option

Read More »

Share:

Facebook
Twitter
LinkedIn